Business · 18/01/2001Updated: 10/17/2026 · 1 min read

FDA Proposes Changes to Confidentiality of Information for Human Gene Therapy and Xenotransplantation

The FDA is proposing to make certain data and information related to human gene therapy and xenotransplantation publicly available, while also requiring sponsors to submit this information for public disclosure, in an effort to promote transparency and public education on public health and safety issues.